Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
复制标题
异甘草酸镁在奥沙利铂诱导的肝损伤模型中具有保肝作用
DOI:
10.3892/ijmm.2018.3787
复制
发表时间:
2018-10
影响因子:
5.4
通讯作者:
Niu J
中科院分区:
文献类型:
--
作者:
Zou X;Wang Y;Peng C;Wang B;Niu Z;Li Z;Niu J
Oxaliplatin is a core chemotherapeutic agent used for the treatment of colorectal liver metastasis; however, liver injury caused by oxaliplatin increases the risk of peri-operative morbidity and mortality. Magnesium isoglycyrrhizinate (MgiG) is a magnesium salt of 18-α glycyrrhizic acid stereo-isomer that has demonstrated liver-protective effects against toxins and hepatitis. In the present study, the liver-protective effect of MgiG against oxaliplatin-induced hepatic injury was examined in vitro and in vivo. The results demonstrated that MgiG had a protective effect against oxaliplatin-induced liver injury, as evidenced by the alleviation of hepatic pathological damage and transaminase levels. The protective effect of MgiG was demonstrated to be correlated with inhibition of oxidative stress, the interleukin-6 pathway and the coagulation system. Altogether, the present findings suggested that MgiG may have potential value in the clinical prevention and treatment of oxaliplatin-induced liver injury.
登录
查看更多内容
影响因子:
3.7
作者:
Kelley MR;Jiang Y;Guo C;Reed A;Meng H;Vasko MR
通讯作者:
Vasko MR
影响因子:
4.6
作者:
Li Fei-Yan;Xie Hao;Wang Guang-Ji
通讯作者:
Wang Guang-Ji
影响因子:
2.1
作者:
BRAY, TM;TAYLOR, CG
通讯作者:
TAYLOR, CG
DOI:
10.1016/j.bbrc.2017.11.014
发表时间:
2018-01-01
影响因子:
3.1
作者:
Liu, Miao;Xu, Hanying;Li, Yanchun
通讯作者:
Li, Yanchun
影响因子:
37.8
作者:
ANGLETON, P;CHANDLER, WL;SCHMER, G
通讯作者:
SCHMER, G